Assembly Biosciences (ASMB) Retained Earnings (2010 - 2026)
Assembly Biosciences' (ASMB) quarterly Retained Earnings came in at -$841.1 million in Q1 2026, down 332360.87% year-on-year from N/an in Q1 2025, and down 2051426.83% quarter-over-quarter from -$41000.0 in Q4 2025.
Assembly Biosciences (ASMB) Retained Earnings (2010 - 2026) Analysis & Trends
Assembly Biosciences' Retained Earnings history runs 17 years deep, the most recent figure standing at -$841.1 million for Q1 2026.
- On a quarterly basis, Retained Earnings fell 332360.87% year-over-year to -$841.1 million in Q1 2026; TTM through Mar 2026 was -$841.1 million, a 332360.87% decrease from a year earlier, with the FY2025 full-year figure at -$41000.0, up 100.0% from the prior year.
- Retained Earnings slipped to -$841.1 million in Q1 2026 per ASMB's latest filing, from -$41000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at -$41000.0 in Q4 2025 and bottomed at -$844.9 million in Q2 2025.
- The 5-year median for Retained Earnings is -$513000.0 (2023), against an average of -$317.0 million.
- Across the five-year window, Retained Earnings tumbled 1019560.49% in 2024 and surged 100.0% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$724.5 million in 2022, then soared by 99.99% to -$81000.0 in 2023, then tumbled by 1019560.49% to -$825.9 million in 2024, then jumped by 100.0% to -$41000.0 in 2025, then slumped by 2051426.83% to -$841.1 million in 2026.
- Per Business Quant, the three latest ASMB Retained Earnings figures stand at -$841.1 million (Q1 2026), -$41000.0 (Q4 2025), and -$90000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Assembly Biosciences | 282.74 Mn | 56.14 Mn | - | -841.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -841.13 Mn |
| Dec 31, 2025 | -41,000.00 |
| Sep 30, 2025 | -90,000.00 |
| Jun 30, 2025 | -844.94 Mn |
| Mar 31, 2025 | -253,000.00 |
| Dec 31, 2024 | -825.93 Mn |
| Sep 30, 2024 | -815.59 Mn |
| Jun 30, 2024 | -293,000.00 |
| Mar 31, 2024 | -239,000.00 |
| Dec 31, 2023 | -81,000.00 |
| Sep 30, 2023 | -275,000.00 |
| Jun 30, 2023 | -325,000.00 |
| Mar 31, 2023 | -513,000.00 |
| Dec 31, 2022 | -724.52 Mn |
| Sep 30, 2022 | -999,000.00 |
| Jun 30, 2022 | -678.98 Mn |
| Mar 31, 2022 | -654.52 Mn |
| Dec 31, 2021 | -419,000.00 |
| Sep 30, 2021 | -288,000.00 |
| Jun 30, 2021 | -273,000.00 |